Is EQRXW or DIVO a better dividend investment in 2026?

EQRXW currently yields 4395.60% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: EQRXW offers higher current income.

What is the dividend yield difference between EQRXW and DIVO?

EQRXW has a forward dividend yield of 4395.60% ($2.00/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 4389.11 percentage points.

Home › Compare › EQRXW vs DIVO

EQRXW vs DIVO: Dividend Comparison 2026

EQRXW yields 4395.60% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EQRXW wins by $17844003331690.01M in total portfolio value

INVESTMENT

TIME HORIZON10 years

EQRXW

● Live price

4395.60%

Share price

$0.05

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$17844003331690.04M

Annual income

$17,079,643,292,413,290,000.00

Full EQRXW calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — EQRXW vs DIVO

📍 EQRXW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	EQRXW	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, EQRXW + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

EQRXW pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EQRXW

Annual income on $10K today (after 15% tax)

$373,626.37/yr

After 10yr DRIP, annual income (after tax)

$14,517,696,798,551,296,000.00/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, EQRXW beats the other by $14,517,696,798,551,296,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EQRXW + DIVO for your $10,000?

EQRXW: 50%DIVO: 50%

100% DIVO50/50100% EQRXW

Portfolio after 10yr

$8922001665845.04M

Annual income

$8,539,821,646,206,645,000.00/yr

Blended yield

95.72%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EQRXW buys

DIVO buys

No recent congressional trades found for EQRXW or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricEQRXWDIVO

Forward yield	4395.60% ✓	6.49%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$17844003331690.04M ✓	$30.7K
Annual income after 10y	$17,079,643,292,413,290,000.00 ✓	$981.68
Total dividends collected	$17792054110403.60M ✓	$8.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: EQRXW vs DIVO ($10,000, DRIP)

Year	EQRXW Portfolio	EQRXW Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$450,260	$439,560.44	$11,349	$649.42	+$438.9K → EQRXW
2	$18,978,664	$18,496,885.68	$12,833	$688.83	+$18.97M → EQRXW
3	$748,953,345	$728,646,173.66	$14,459	$727.90	+$748.94M → EQRXW
4	$27,674,743,815	$26,873,363,736.79	$16,238	$766.49	+$27674.73M → EQRXW
5	$957,652,835,286	$928,040,859,403.20	$18,179	$804.47	+$957652.82M → EQRXW
6	$31,037,578,041,538	$30,012,889,507,782.54	$20,293	$841.71	+$31037578.02M → EQRXW
7	$942,293,671,101,243	$909,083,462,596,797.50	$22,591	$878.14	+$942293671.08M → EQRXW
8	$26,802,238,424,024,828	$25,793,984,195,946,500.00	$25,087	$913.65	+$26802238424.00M → EQRXW
9	$714,355,176,894,161,700	$685,676,781,780,455,000.00	$27,791	$948.18	+$714355176894.13M → EQRXW
10	$17,844,003,331,690,041,000	$17,079,643,292,413,290,000.00	$30,718	$981.68	+$17844003331690.01M → EQRXW

EQRXW vs DIVO: Complete Analysis 2026

EQRXW — Stock

EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. Its product pipeline in development includes Aumolertinib, an EGFR inhibitor for the treatment of ?EGFR-mutated? non-small cell lung cancer (NSCLC); Sugemalimab, an anti-PD-L1 antibody for the treatment of ?stage III and IV ?NSCLC; Lerociclib, a CDK4/6 inhibitor to treat HR+/HER2- breast cancer; and EQ176, an anti-PD-1?antibody for the treatment of liver cancer. The company has partnerships with Exscientia and AbCellera Biologics Inc. EQRx, Inc. was founded in 2020 and is based in Cambridge, Massachusetts.

Full EQRXW Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this EQRXW vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EQRXW vs SCHD EQRXW vs JEPI EQRXW vs O EQRXW vs KO EQRXW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.